Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
1. Ted Schroeder joins Phathom Pharmaceuticals' Board of Directors. 2. Schroeder has extensive experience in biopharmaceutical leadership. 3. Phathom aims to accelerate commercial momentum for VOQUEZNA®. 4. Schroeder also sits on the board of Cidara Therapeutics (CDTX). 5. His expertise will support strategic development at Phathom.